LENSAR Inc (LNSR) - Total Assets
Based on the latest financial reports, LENSAR Inc (LNSR) holds total assets worth $70.20 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See LNSR book value for net asset value and shareholders' equity analysis.
LENSAR Inc - Total Assets Trend (2018–2024)
This chart illustrates how LENSAR Inc's total assets have evolved over time, based on quarterly financial data.
LENSAR Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
LENSAR Inc's total assets of $70.20 Million consist of 63.3% current assets and 36.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.5% |
| Accounts Receivable | $6.48 Million | 9.8% |
| Inventory | $11.43 Million | 17.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $6.11 Million | 9.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how LENSAR Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LENSAR Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LENSAR Inc's current assets represent 63.3% of total assets in 2024, an increase from 40.7% in 2018.
- Cash Position: Cash and equivalents constituted 24.5% of total assets in 2024, up from 11.6% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 42.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 17.2% of total assets.
LENSAR Inc Competitors by Total Assets
Key competitors of LENSAR Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
LENSAR Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.24 | 3.37 | 6.90 |
| Quick Ratio | 0.67 | 2.10 | 5.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $8.70 Million | $27.72 Million | $49.92 Million |
LENSAR Inc - Advanced Valuation Insights
This section examines the relationship between LENSAR Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.17 |
| Latest Market Cap to Assets Ratio | 1.01 |
| Asset Growth Rate (YoY) | -4.7% |
| Total Assets | $66.30 Million |
| Market Capitalization | $67.01 Million USD |
Valuation Analysis
Above Book Valuation: The market values LENSAR Inc's assets above their book value (1.01x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: LENSAR Inc's assets decreased by 4.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for LENSAR Inc (2018–2024)
The table below shows the annual total assets of LENSAR Inc from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $66.30 Million | -4.73% |
| 2023-12-31 | $69.58 Million | +24.61% |
| 2022-12-31 | $55.84 Million | -15.98% |
| 2021-12-31 | $66.47 Million | -15.99% |
| 2020-12-31 | $79.12 Million | +129.09% |
| 2019-12-31 | $34.54 Million | +19.56% |
| 2018-12-31 | $28.89 Million | -- |
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcom… Read more